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Abstract
Background: Hypercapnia, with its associated acidosis (HCA), is a consequence of
respiratory failure and is also seen in critically ill patients managed with conventional
“protective” ventilation strategies. Nuclear factor kappa-B (NF-κB), a pivotal transcription
factor, is activated in the setting of injury and repair and is central to innate immunity.
We have previously established that HCA protects against ventilation-induced lung injury
in vivo, potentially via a mechanism involving inhibition of NF-κB signaling. We wished
to further elucidate the role and mechanism of HCA-mediated inhibition of the NF-κB
pathway in attenuating stretch-induced injury in vitro.
Methods: Initial experiments examined the effect of HCA on cyclic stretch-induced
inflammation and injury in human bronchial and alveolar epithelial cells. Subsequent
experiments examined the role of the canonical NF-κB pathway in mediating stretch-
induced injury and the mechanism of action of HCA. The contribution of pH versus CO2
in mediating this effect of HCA was also examined.
Results: Pulmonary epithelial high cyclic stretch (22 % equibiaxial strain) activated
NF-κB, enhanced interleukin-8 (IL-8) production, caused cell injury, and reduced
cell survival. In contrast, physiologic stretch (10 % strain) did not activate
inflammation or cause cell injury. HCA reduced cyclic mechanical stretch-induced
NF-κB activation, attenuated IL-8 production, reduced injury, and enhanced
survival, in bronchial and alveolar epithelial cells, following shorter (24 h) and
longer (120 h) cyclic mechanical stretch. Pre-conditioning with HCA was less
effective than when HCA was applied after commencement of cell stretch. HCA
prevented the stretch-induced breakdown of the NF-κB cytosolic inhibitor IκBα, while
IκBα overexpression “occluded” the effect of HCA. These effects were mediated by a
pH-dependent mechanism rather than via CO2 per se.
Conclusions: HCA attenuates adverse mechanical stretch-induced epithelial injury and
death, via a pH-dependent mechanism that inhibits the canonical NF-κB activation by
preventing IκBα breakdown.
Keywords: Acute respiratory distress syndrome, Inflammation, Ventilation-induced lung
injury, Repair, Hypercapnic acidosis, Nuclear factor kappa-B
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Background
Acute respiratory distress syndrome (ARDS) is a devastating disorder that has high
mortality rates [1]. ARDS is characterized by pulmonary edema, hypoxemia, and severe
inflammation of the lung parenchyma [1]. Mechanical ventilation, while life-saving, can
cause additional lung damage due to repetitive cyclic mechanical stretch of the lung result-
ing in increased inflammation and lung tissue injury—this is termed “ventilator induced
lung injury” (VILI) [2]. Protective ventilator strategies, that reduce the potential for excessive
lung stretch, have been demonstrated to improve outcome [3] and now constitute the
standard of care for these patients [4]. However, reducing tidal and minute ventilation re-
sults in less effective CO2 clearance. The resulting hypercapnic acidosis (HCA) is termed
“permissive hypercapnia” and is not traditionally considered to have an active role [5, 6].
Previous pre-clinical studies, from our group and others, have demonstrated that HCA
may exert protective effects in models of ARDS induced by free radicals [7], endotoxin [8],
both primary [9, 10] and secondary [11] ischemia-reperfusion, and high lung stretch
[12, 13]. HCA can also exert deleterious effects, including delayed plasma membrane
re-sealing [14] and reduced pulmonary epithelial wound closure [15]. While HCA
exerts beneficial effects in early lung injury [16–18] and systemic sepsis [19, 20],
prolonged HCA may retard bacterial killing and worsen pneumonia-induced lung
injury [21, 22].
These effects of HCA may be mediated at least in part via inhibition of nuclear
factor kappa-B (NF-κB), a pivotal regulator of genes central to lung injury,
inflammation, and repair [23–26]. Our group has demonstrated that HCA attenu-
ates VILI severity in vivo, potentially via inhibition of NF-κB signaling [27]. HCA
also attenuated cyclic mechanical stretch-induced inflammation injury and re-
duced NF-κB activation [27]. Most recently, we have demonstrated the effects
and mechanisms by which HCA modulates the canonical NF-κB pathway in
sepsis-induced lung injury [28].
In the current studies, we wished to further elucidate the role of the NF-κB pathway
in mediating the protective effects of HCA in stretch-induced injury. Specifically, we
hypothesized that (1) HCA would attenuate stretch-induced cell inflammation and
injury and improve cell survival in both the bronchial and alveolar epithelium; (2) that
the protective effects of HCA seen in early stretch would persist in the setting of
prolonged cyclic mechanical stretch; (3) that the effects of HCA on stretch would be
mediated via inhibition of the NF-κB pathway; and (4) the effect of HCA would be me-
diated by a pH (i.e. acidosis) rather than a CO2 effect per se.
Methods
Pulmonary epithelial cell cultures
Human bronchial epithelial cells (HBE and BEAS-2B lines) and type II alveolar
A549 cells were used in all experiments. BEAS-2B cells (ATCC®, Manassas, VA,
USA) are a cell line derived from normal bronchial epithelium, immortalized using
a replication-defective SV40/adenovirus 12 hybrid, and cloned. These cells were
subcultured in growth medium (Dulbecco’s Modified Eagle’s Medium/Nutrient F12
Ham; Sigma-Aldrich Co., Dublin, Ireland), supplemented with 10 % fetal calf
serum, penicillin G (100 U/mL) and streptomycin (100 μg/mL) at 37 °C in a
Horie et al. Intensive Care Medicine Experimental  (2016) 4:8 Page 2 of 14
humidified incubator saturated with a gas mixture containing 5 % CO2 in air, and
used at passages 5–15. The 16HBE14o-(HBE) transformed epithelial cell line was a
gift from D. Gruender (University of Vermont, Burlington, VT, USA) as cryopre-
served passage 1 culture and used at passages 4–14. These are virally immortalized
primary human cells which form correctly polarized cell layers in vitro [29]. These
cells were subcultured into growth medium (Minimum Essential Medium, Alpha
Modification; Sigma-Aldrich Co.), supplemented with 10 % fetal calf serum, penicil-
lin G (100 U/ml) and streptomycin (100 μg/ml).
A549 cells were purchased from The European Collection of Cell Cultures
(Porton Down, UK) as cryopreserved 90-passage culture and used at passages
91–95. All A549 cells and derivatives were passaged in growth medium (RPMI-
1640; Sigma-Aldrich Co.), supplemented with 10 % fetal calf serum, penicillin G
(100 U/mL), and streptomycin (100 μg/mL) at 37 °C in a humidified incubator
saturated with a gas mixture containing 5 % CO2 in air. In some experiments,
the A549/NF-κB-luc cell line, which incorporates a chromosomally integrated lu-
ciferase reporter of NF-κB transcription factor activity, was used (P/N LR0051;
Panomics, Fremont, CA, USA). To obtain this cell line, A549 cells were co-
transfected with pNF-κB-luc and pHyg followed by hygromycin selection.
Hygromycin-resistant cell clones were selected using a functional tumor necrosis
factor-α (TNF-α) assay that induces luciferase activity. In another experimental
series, the A549/NF-κB-luc cell line was stably transfected with an IκBα super-
repressor under the control of a chicken β-actin promoter and then selected with
G418 antibiotic (Sigma-Aldrich Co.). This super-repressor ensures that IκBα can-
not be phosphorylated and hence canonical NF-κB activation is inhibited. Clones
were evaluated based on their ability to prevent IL-1β (10 ng/ml) induction of
the luciferase reporter (Additional file 1: Figure S1).
Pulmonary epithelial cyclical stretch injury model
HBE, BEAS-2B or A549/NF-κB-luc cells were seeded to Bioflex six-well plates
(Flexcell International, Hillsborough, NC, USA) at 6 × 104 cells/cm2, incubated for
48 h, and re-fed with fresh complete medium. They were then mounted onto the
Flexcell FX-4000 T® Tension Plus® baseplate (Flexcell International) where they
were pre-conditioned in either normocapnic (5 % CO2) or hypercapnic conditions
(15 % CO2) for 1 h before being subjected to 22 % equibiaxial stretch at a fre-
quency of 0.1 Hz for 24 and 120 h under their respective conditions. Non-
stretched cells under identical atmospheric conditions were used as controls for
these experiments, based on our demonstration that physiologic stretch did not
produce any evidence of cell inflammation or injury (Additional file 1: Figure S2).
Experimental design
Series 1–2: effect of HCA on bronchial epithelial stretch-induced injury
HBE (series 1) and BEAS-2B (series 2) confluent epithelial layers were equilibrated in nor-
mocapnia or HCA and then subjected to injurious cyclic stretch (i.e., 22 % equibiaxial
stretch at a frequency of 0.1 Hz in the Flexcell FX-4000T®) for 24 h. The potential for HCA
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to attenuate stretch-induced inflammation, maintain cell membrane integrity, and enhance
cell survival in HBE and BEAS-2B epithelial layers was then determined.
Series 3–4: effect of HCA on alveolar cell stretch injury
Confluent alveolar epithelial A549/NF-κB-luc cell layers were equilibrated in normo-
capnia or HCA and then subjected to injurious cyclic stretch for 24 (series 3), or 120
(series 4) h, and the effect of HCA was assessed as described above.
Series 5: effect of pre- versus post-conditioning with HCA
Confluent A549/NF-κB-luc cell layers were allocated to normocapnia, HCA pre-
incubation followed by normocapnia during cyclic stretch (“HCA-pre”), HCA at the
commencement of cyclic stretch (“HCA-post”), or HCA prior to and during stretch
(“HCA-combined”). All epithelial layers were subjected to cyclic stretch for 120 h.
Series 6: mechanism of action of HCA on stretch-induced NF-κB
The effect of cyclic stretch and HCA on inhibitory-κB-alpha (IκBα), the canonical
NF-κB cytosolic inhibitor, was examined. Briefly, A549 monolayers were equilibrated
in normocapnia or HCA and then subjected to cyclic stretch for 0, 30, 60, and
120 min, and cytosolic concentrations of IκBα were determined.
The potential for IκBα overexpression to attenuate stretch injury and “occlude” the
effects of HCA was then determined. Stably transfected A549/NF-κB-luc cells overex-
pressing IκBα (methods described above) were seeded to laminin coated Bioflex six-
well plates at 6 × 104 cells/cm2 and left to reach confluent monolayers for 48 h. These
cells were then washed, re-fed, and pre-conditioned as described above before being
subjected to injurious cyclic stretch for 120 h.
Series 7: acidosis versus CO2 on stretch-induced epithelial injury
Metabolic acidosis was produced by adding strong acid (0.02 M Hydrochloric
acid) to titrate media pH to that seen with HCA conditions, i.e., 7.1, when incu-
bated in normocapnia. Buffered hypercapnia (BHA) was produced by buffering
media pH to normal under hypercapnic conditions using 0.04 M sodium bicar-
bonate. Finally sodium chloride (either 0.04 or 0.02 M) was added to all groups
to ensure that all groups were equi-osmolar. These groups were then subjected
to injurious cyclic stretch as described above.
Assessment of NF-κB activity, inflammation, and cell viability
At the end of each experiment, medium was harvested and the cells scraped from each
well into 1 mL of phosphate buffered saline (PBS). Cells were pelleted at 400×g for
5 min and resuspended in 1 mL of fresh PBS.
NF-κB activity
Five hundred microliters of intact harvested cells were pelleted at 400×g for 5 min and
resuspended in 100 μL of Reporter Lysis Buffer (Promega Corp., Madison, WI, USA),
before being subjected to a freeze/thaw cycle. Forty microliters of cell lysate was mixed
with 40 μL of Bright-Glo luciferase substrate (Promega Corp.) and luminescence
assessed in a VICTOR™ X plate reader (Perkin Elmer, Waltham, MA, USA) [15].
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Cytosolic IκBα assessment
Three hundred microliters of intact-harvested cells were pelleted at 400×g for
5 min and resuspended in 50 μL of 1× Laemmli SDS-PAGE buffer (0.1 % 2-
mercaptoethanol, 0.0005 % bromophenol blue, 10 % glycerol, 2 % SDS, 2 %,
63 mM Tris-HCl pH 6.8) and heated to 100 °C for 2 min. Proteins were separated
on polyacrylamide gels (Pierce Biotechnology, Rockford, IL, USA), transferred to
nitrocellulose membranes, blocked, and probed using anti-total IκBα (Cell Signaling
Technology) and secondary-HRP (Sigma-Aldrich Co.) antibodies in 5 % (w/v) milk
powder-PBS. Membranes were soaked in chemiluminescent substrate (Pierce Bio-
technology) and imaged.
For IκBα ELISA, cells were scraped into 1 mL of ice-cold PBS, pelleted at 500×g
for 5 m and resuspended in 100 μL of 1 % Triton (v/v) in PBS with protease in-
hibitors (Pierce protease inhibitor mini tablets, EDTA-free; Fisher Scientific Ireland
Ltd, Dublin, Ireland). A BCA protein assay was performed and equal quantities of
protein added to a PathScan® Total IκBα Sandwich ELISA (Cell Signaling Technol-
ogy, Danvers, MA, USA) as per manufacturer’s instructions. Total IκBα present
was expressed as fold of the control no-stretch group.
Viability assay
Fifty microliters of intact harvested cells were added to a 96-well plate. One hun-
dred microliters of methylthiazolyldiphenyl-tetrazolium bromide (MTT; Sigma-
Aldrich Co.) solution (100 μg/mL in complete medium) was added to each well,
and the plate returned to a tissue culture incubator (5 % CO2) for 2 h. The
media and MTT solution was removed, 100 μL of dimethyl sulfoxide (DMSO)
was added to each well, the plates were left on an orbital mixer for 30 min, and
absorbances read in a VICTOR™ X plate reader at 550 nm wavelength [30].
LDH assay
Epithelial injury was assessed by measuring lactate dehydrogenase (LDH), an intra-
cellular enzyme that when present in the medium reflects the extent of epithelial
cell damage and lysis. Fifty microliters of harvested medium was used with the
CytoTox 96 Non-Radioactive Cytotoxicity Assay Kit (Promega Corp.) to assess
LDH release.
IL-8 ELISA
Epithelial inflammation was assessed by quantifying the secretion of the NF-κB-
dependent cytokine IL-8. The medium was assessed for cellular secretion of IL-8 using
an IL-8 sandwich ELISA DuoSet kit (R&D Systems Inc., Minneapolis, MN, USA) as per
manufacturer’s instructions.
Data presentation and analysis
All data was analyzed using a one-way analysis of variance, with group as the
factor. Post hoc analysis was carried out with the Student-Newman-Keuls test or
Mann-Whitney U test with the Bonferroni correction for multiple comparisons, as
appropriate. The assumptions underlying all models were checked using suitable
residual plots. A p value of <0.05 was considered statistically significant.
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Results
HCA inhibits bronchial epithelial stretch-induced injury
Twenty-four hours of cyclic cell stretch induced the release of pro-inflammatory
IL-8 in both HBE (Fig. 1a) and BEAS-2B (Fig. 1b) bronchial epithelial layers, and
this was inhibited by HCA. HCA abolished cell stretch-induced cell membrane
injury and rupture, as reflected by medium LDH concentrations, in both HBE
(Fig. 1c) and BEAS-2B (Fig. 1d) epithelial bronchial cultures. HCA also
Fig. 1 HCA inhibits bronchial epithelial stretch-induced injury. Hypercapnic acidosis decreased 24-h
stretch-induced interleukin-8 secretion (a, b), preserved membrane integrity as assessed by epithelial
LDH leakage (c, d), and maintained cell viability (e, f) in human bronchial epithelial cells and BEAS-2B
cells, respectively. Note: *P < 0.05 versus normocapnia for each condition
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attenuated cell stretch-induced cell death, in HBE (Fig. 1e) but not in BEAS-2B
(Fig. 1f ) epithelial bronchial cultures.
HCA inhibits prolonged alveolar epithelial stretch-induced injury
Cyclic stretch-induced a progressive activation of NF-κB at 24 and 120 h in A549
epithelial layers. HCA potently inhibited stretch-induced NF-κB activation at each time
point (Fig. 2a). Cyclic stretch enhanced alveolar epithelial IL-8 secretion at 24 and
120 h, and this was attenuated by HCA at each time point (Fig. 2b). HCA abolished
cyclic stretch-induced cell membrane injury at each time point (Fig. 2c). The progres-
sive decrease in cell survival induced by cell stretch at 24 and 120 h was also abolished
by HCA (Fig. 2d).
Effect of pre- versus post-conditioning with HCA
Pre-conditioning with HCA was less effective compared to post-conditioning. Pre-
conditioning modestly decreased NF-κB activation (Fig. 3a), but did not alter the effect
of high stretch on IL-8 production (Fig. 3b), LDH leakage (Fig. 3c), or cell survival
(Fig. 3d). In contrast, exposure of the epithelial layers to HCA post-commencement of
cell stretch had the same effect as exposure to HCA prior to and post-cyclic stretch.
Fig. 2 HCA attenuates alveolar epithelial injury following 24 and 120 h of cyclic mechanical stretch.
HCA decreased stretch-induced activation of NF-κB (a), attenuated IL-8 secretion (b), reduced epithelial
LDH leakage (c), and maintained cell viability (d) following 24 and 120 h of cyclic mechanical stretch
in A549 alveolar epithelial cells. Note: *P < 0.05 versus normocapnia for each condition. Abbreviations:
Sham unstretched cells
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HCA inhibits stretch-induced canonical NF-κB activation
HCA attenuates stretch-induced IκBα decrease
Cyclic epithelial stretch decreased cytosolic concentrations of the IκBα protein,
which normally binds and inactivates NF-κB, at 15, 30, and 60 min, with restor-
ation at 120 min (Fig. 4a). This decrease in cytosolic IκBα was abolished by HCA
(Fig. 4a).
IκBα “occludes” the effect of HCA
Overexpression of IκBα directly attenuated the increase in stretch-induced NF-κB
activation (Fig. 4b). IκBα “occluded” the effect of HCA on NF-κB activation, in that
there was no further decrease in NF-κB activation in the presence of HCA in cells
overexpressing IκBα (Fig. 4b). IκBα overexpression directly attenuated the increase
in stretch-induced cell injury, as measured by LDH concentrations, and largely, but
not completely, “occluded” this protective effect of HCA (Fig. 4c). IκBα overexpres-
sion also directly attenuated the decrease in stretch-induced cell viability and again
“occluded” this protective effect of HCA (Fig. 4d).
Fig. 3 Effect of pre- versus post-conditioning with HCA. Pre-conditioning with HCA modestly decreased NF-κB
activation (a) but did not alter the effect of high stretch on IL-8 production (b), LDH leakage (c), or cell survival
(d). In contrast, exposure of the epithelial layers to HCA post-commencement of cell stretch was as
effective as exposure to HCA prior to and post-commencement of cyclic stretch. Note: *P < 0.05 versus
normocapnia; †P < 0.05 versus HCA-pre-conditioning. Abbreviations: Sham unstretched cells under
normocapnia, Normo high cyclical stretch with normocapnia, HCA-pre hypercapnia exposure prior to cell
stretch, HCA-post hypercapnia exposure commenced after start of cell stretch, HCA-combined hypercapnia
exposure both prior to and during cell stretch high cyclical stretch with hypercapnia
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Acidosis versus CO2 in stretch-induced epithelial injury
Cyclic stretch activated NF-κB at 72 hours in A549 epithelial layers (Fig. 5a). Both
HCA and metabolic acidosis (MA), but not buffered hypercapnia (BHC), inhibited
this stretch-induced NF-κB activation (Fig. 5a). Cyclic stretch-induced alveolar
epithelial IL-8 secretion was attenuated by acidosis—both hypercapnic and meta-
bolic—but not by BHC (Fig. 5b). Both HCA and MA abolished cyclic stretch-
induced cell membrane injury but BHC was not protective (Fig. 5c). The decrease
in cell survival induced by cell stretch was also abolished by acidosis—both HCA
and MA—but BHC was ineffective (Fig. 5d).
Discussion
HCA is a consequence of respiratory failure and is particularly frequent in critically
ill patients managed with conventional “protective” ventilation strategies. NF-κB is
an important transcription factor that is activated in the setting of inflammation
and repair and is central to innate immunity [31]. Ventilatory strategies incorporat-
ing permissive HCA have been shown to enhance patient survival in a clinical set-
ting of ARDS by alleviating stretch-induced injury [3, 32–34]. While the associated
Fig. 4 Effects of HCA on NF-κB pathway mediated via IκBα. ELISA with embedded Western blot demonstrating
that HCA prevents the stretch-induced decrement in cytoplasmic concentrations of the NF-κB inhibitor IκBα (a).
Direct overexpression of IκBα attenuates the deleterious effects of stretch in normocapnia-exposed epithelial layers,
decreasing NF-κB activation (b), reducing epithelial LDH leakage (c) and preserving cell viability (d). HCA did further
reduce medium LDH but had no effect on NF-κB or on cell viability, in the presence of prior IκBα overexpression.
Note: *P< 0.05 versus normocapnia-empty vector, †P< 0.05 versus normocapnia-IκBα-SR. Abbreviations:
Normocapnia-Sham unstretched cells with normocapnia, Normocapnia-Stretch high cyclical stretch
with normocapnia, HCA-Sham unstretched cells with normocapnia, HCA-Stretch high cyclical stretch
with hypercapnia
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HCA is generally considered a bystander, work from our group and others has
demonstrated the potential for HCA to exert potent biologic effects in preclinical
lung injury models, with several key effects mediated via inhibition of NF-κB sig-
naling. This current work demonstrates that HCA reduces stretch-induced bron-
chial and alveolar epithelial cell NF-κB activation and consequent inflammation,
injury, and cell death. These protective effects of HCA are mediated via the inacti-
vation of the canonical NF-κB pathway and appear to be mediated by the acidosis
rather than the CO2 per se.
Deleterious effects of excessive cell stretch
Our findings confirm the deleterious effects of prolonged excessive cell stretch on
the alveolar epithelium. Positive pressure ventilation can severely injure the lungs
of already compromised ARDS patients, and here, we show that excessive cell
stretch severely injures both bronchial and alveolar cells by activation of NF-κB, a
finding which confirms and expands on previously published data [27]. Interest-
ingly, our work also shows that HCA can alleviate this cell injury and inflamma-
tion following both short- and long-term stretch injury, an important finding
Fig. 5 The effects of HCA appear to be mediated via pH-dependent effects rather than via CO2. Metabolic
acidosis (MA), at a pH comparable to that seen with HCA, decreases stretch-induced activation of NF-κB (a),
decreases IL-8 secretion (b), reduces epithelial LDH leakage (c), and maintains cell viability (d) following cyclic
mechanical stretch. In contrast, these effects are abrogated by buffering of the hypercapnic acidosis (BHC). Note:
*P < 0.05 versus normocapnia. Abbreviations: Sham unstretched cells under normocapnia, Normo high cyclical
stretch with normocapnia, HCA high cyclical stretch with hypercapnia, MA high cyclical stretch with metabolic
acidosis, BHC high cyclical stretch with buffered hypercapnia
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from a clinical perspective, suggesting that permissive/therapeutic hypercapnia
could be of benefit to the patient throughout the ventilation period.
Protective effects of HCA in cell stretch injury
Furthermore, our findings demonstrate that HCA directly attenuates cell stretch-
induced injury. HCA reduced stretch-induced bronchial and alveolar epithelial stretch-
induced inflammation, as evidenced by pulmonary IL-8 secretion. HCA also attenuated
cellular injury and maintained cell membrane integrity, as evidenced by reduced
concentrations of LDH, an intracellular enzyme which is released into the medium
during cell disruption or necrosis. HCA also maintained cellular viability, prevent-
ing stretch-induced cell death.
HCA attenuates stretch-induced NF-κB activation
In this study, we have shown that mechanical stretch triggers the NF-κB signaling path-
way. NF-κB activation in turn results in epithelial inflammation, loss of cell membrane
integrity, and ultimately in cell death. When IκBα is directly overexpressed in the epi-
thelial layers, it reduced stretch-induced NF-κB activation, decreased epithelial IL-8
production, maintained cell membrane integrity, and reduced stretch-induced cell
death, demonstrating that these deleterious effects of cyclic stretch are mediated via
NF-κB activation. HCA inhibited NF-κB activation, decreasing the detrimental effects
of stretch injury.
Mechanism by which HCA inhibits NF-κB pathway
IκBα is normally located in the cytoplasm, where it binds to and inactivates NF-κB.
When the canonical NF-κB pathway is activated, the IKK-complex phosphorylates
IκBα, which is then subsequently degraded. In these studies, HCA blocked the stretch-
induced decrease of cytosolic concentrations of IκBα. In subsequent studies, the effect
of HCA was comparable to that seen with direct IκBα overexpression, while the com-
bination of IκBα overexpression and HCA was also comparably effective. Overexpres-
sion of IκBα greatly reduced or entirely abrogated the effect of HCA on stretch-
induced inflammation, cell membrane dysfunction, or cell viability. This suggests that
IκBα “occluded” the effect of HCA, suggesting that these effects of HCA are mediated
largely via inhibition of the canonical NF-κB pathway.
These data support and extend prior findings by our group and others. Takeshita et al.
showed HCA could inhibit endotoxin-induced canonical NF-κB activation and IκBα
degradation in human pulmonary artery endothelial cells [30]. We have recently demon-
strated that HCA directly reduces the kinase activity of the IKK complex and reduces
IKK-mediated phospho-inactivation of IκBα [28], a finding entirely consistent with the
findings from these studies. Taken together, these findings suggest that inhibition of the
IKK-IκBα interaction constitutes a key mechanism by which HCA suppresses canonical
NF-κB activation in response to stimuli such as endotoxin or high stretch.
Role of acidosis versus CO2
The beneficial effects of HCA on stretch-induced pulmonary injury appear to be medi-
ated by the pH change, i.e. the acidosis that is caused by the HCA rather than the
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increase in CO2 per se. In fact, buffering the HCA completely abolished its effect
on the NF-κB activation pathway and abrogated the protective effects on inflamma-
tion, cell membrane leak, and cell viability. This contrasts somewhat with the find-
ings of Takeshita et al., who demonstrated that buffered hypercapnia inhibited
endotoxin-induced canonical NF-κB activation by suppressing IκBα degradation
[30]. Furthermore, the inhibitory effects of HCA on wound healing, which were
mediated at least in part via inhibition of NF-κB, appeared to be a function of the
hypercapnia rather than the acidosis per se. Cummins et al., showed that hypercap-
nia inhibited endotoxin induced NF-κB activation in fibroblasts via activation of
the non-canonical pathway [35]. Likely explanations for the divergent findings in-
clude the mechanism of injury—stretch versus endotoxin induced—and the cell
types studied—epithelium versus endothelium and fibroblasts.
Limitations
There are some of limitations to these studies. Our use of non-stretched cells as controls
for these experiments was based on our demonstration that physiologic stretch did not
produce any evidence of cell inflammation or injury (Additional file 2: Figure e1).
While we have previously examined the effects of greater degrees of HCA than
those used in the current study [27], we have not examined the efficacy of less
severe HCA.
Conclusions
We report that HCA enhances cell viability and protects against epithelial damage after
early or prolonged stretch-induced injury by inhibiting canonical NF-κB activation
through a pH-dependent mechanism. These findings further our knowledge in regard
the effects of HCA on the NF-κB pathway and its effects in a mechanical stretch injury
setting. The demonstration that direct inhibition of the NF-κB pathway is protective in
other diverse pre-clinical non-septic ARDS models [24–26] but is potentially deleteri-
ous in sepsis-induced ARDS [36] underlines the importance of understanding the inter-
action between HCA and this pivotal pathway.
Key message
Hypercapnic acidosis attenuates cyclic mechanical stretch-induced pulmonary epithelial
inflammation, injury, and death via inhibition of stretch activation of canonical NF-κB
pathway activation. This effect was pH rather than CO2 dependent. The precise mech-
anism by which HCA inhibits NF-κB activation appears to be via attenuation of
stretch-induced phospho-inactivation of the cytosolic NF-κB inhibitor IκBα, thereby
preventing the release of the activated NF-κB dimer.
Additional files
Additional file 1: Figure S1. The IkBa-SR gene suppressed IL-1b and TNF-a activation of NF-kB. NF-κB activation
induced by IL-1b and TNF-a activation (both 20 ng/ml) was attenuated by IkBa-SR gene overexpression in alveolar
epithelial A549 cells. (JPG 72 kb)
Additional file 2: Figure S2. Physiologic stretch does not cause pulmonary epithelial inflammation, injury or cell
death. The application of 10 % equibiaxial cyclic stretch for 24 hours did not activate NF-kB (Panel A), increase
interleukin-8 secretion (Panel B), alter membrane integrity as assessed by epithelial LDH leakage (Panel C), or affect
cell viability (Panel D) in alveolar epithelial A549 cells, when compared to unstretched cells. (JPG 200 kb)
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